Product | Product characteristics | Rates on the elements of patient impact (rating 1 = low, 2 = moderate, 3 = high) | Overall score | ||||||
---|---|---|---|---|---|---|---|---|---|
 | ATC class | Route of administration | Originator or generic | Alternative product | Disease | Susceptibility | Costs | Number of patients |  |
BCG instillation | L | Parenteral | Originator | 2 | 3 | 3 | 2 | 2 | 72 |
Risperidone orodispersible tablet | N | Oral | Originator | 2 | 3 | 3 | 3 | 1 | 54 |
Epinephrine injection | C | Parenteral | Originator | 2 | 3 | 2 | 2 | 2 | 48 |
Methoxy polyethylene glycol-epoetin beta injection | B | Parenteral | Originator | 2 | 2 | 2 | 3 | 2 | 48 |
Bendamustine powder for infusion | L | Parenteral | Originator | 2 | 3 | 1 | 3 | 2 | 36 |
Bromperidol drops for oral use | N | Oral | Originator | 2 | 3 | 3 | 2 | 1 | 36 |
Dexamethasone tablet | H | Oral | Generic | 2 | 3 | 1 | 3 | 2 | 36 |
Disulfiram dispersible tablet | N | Oral | Originator | 2 | 3 | 2 | 3 | 1 | 36 |
Feneticilline capsule | J | Oral | Originator | 2 | 2 | 1 | 3 | 3 | 36 |
Flupentixol tablet | N | Oral | Originator | 2 | 3 | 3 | 2 | 1 | 36 |
Ibuprofen granules | M | Oral | Originator | 2 | 3 | 1 | 2 | 3 | 36 |
Isosorbide mononitrate sustained tablet | C | Oral | Originator | 2 | 3 | 1 | 3 | 2 | 36 |
Lamotrigine dispersible tablet | N | Oral | Generic | 2 | 3 | 2 | 3 | 1 | 36 |
Olanzapine orodispersible tablet | N | Oral | Generic | 2 | 3 | 3 | 2 | 1 | 36 |
Pergolide tablet | N | Oral | Generic | 2 | 3 | 2 | 3 | 1 | 36 |
Topiramate tablet | N | Oral | Generic | 2 | 3 | 2 | 3 | 1 | 36 |
Vincristine sulfate injection | L | Parenteral | Generic | 2 | 3 | 1 | 3 | 2 | 36 |